SAN ANTONIO — Fertility preservation and/or assisted reproductive technologies do not increase the risk for short-term cancer recurrence in young ...
News
- Patients With HR-Positive Breast Cancer Can Safely Use ART - Medscape
- Intensity Therapeutics Shares Rise On Positive Phase 2 INVINCIBLE Trial Data Of INT230-6
This data was presented during the 2023 San Antonio Breast Cancer ... Invest in the Best Pharma Stocks by Subscribing to RTT Biotech Investor. Biotech ...
- T-DM1 Falls Short in Elderly Patients With Advanced, HER2+ Breast Cancer
... San Antonio Breast Cancer Symposium 2023. T-DMI failed to show non ... Disclosures: Dr Shimomura declared affiliations with biotech, pharmaceutical, and ...
- MEDSIR presents promising results at SABCS 2023: ATRACTIB and DEBBRAH trials ... - BioSpace
... San Antonio Breast Cancer Symposium (SABCS) that have the potential to ... Biotech Bay · Biotech Beach · BioCapital · BioMidwest · Bio NC · BioForest ...
- Breast cancer survivors may not need so many mammograms after surgery, UK study suggests
Biomedical technology · Cardiology · Dentistry · Diabetes · Diseases, Conditions ... 8, 2023 at the San Antonio Breast Cancer Symposium. Credit: AP ...